Society ❯Public Health ❯Epidemiology

HIV/AIDS

Pre-exposure Prophylaxis (PrEP) Infection Rates

New Biannual HIV Injection Reduces Infection Risk by 96%

Gilead's Lenacapavir Shows 100% Efficacy in HIV Prevention Trial